CliniMACS® Technology In Stem Cell Transplantation Research

Hematopoietic stem cell transplantation (HSCT) continues to evolve, expanding its therapeutic reach beyond malignant disorders to include a growing number of nonmalignant diseases. Despite its promise, HSCT is still accompanied by serious complications such as graft-versus-host disease (GVHD), infections, and poor graft function, which pose significant challenges to both patient outcomes and clinical management. To support researchers and clinicians in addressing these issues, we developed the CliniMACS Systems—advanced technologies designed for GMP-compliant cell depletion and enrichment. These systems enable precise manipulation of cellular products, helping to improve safety and efficacy in HSCT procedures.

If you're working in stem cell research or clinical transplantation, explore how CliniMACS can enhance your workflow and contribute to better patient care.